John Bell

John Bell

Chairman at IMMUNOCORE HOLDINGS PLC

Net worth: 455 888 $ as of 2024-06-29

72 year
Health Technology
Commercial Services
Consumer Services

Profile

John Irving Bell is the founder of The Wellcome Trust Centre for Human Genetics (founded in 1993) and Oxagen Ltd.
(founded in 1997).
He was also the founder of Powderject Pharmaceuticals Plc, Avidex Ltd...
Dr. Bell's current jobs included Chairman-Partnership Board at the Oxford Centre for Diabetes Endocrinology & Metabolism (since 1999), Chairman at The Oxford Health Alliance, GMEC Management Co. Ltd., and the Office for Strategic Co-ordination of Health Research, Chairman at Immunocore Holdings Plc (since 2015), Non-Executive Director at The Jenner Institute Laboratories, Oxford University Hospitals NHS Trust, The Gray Laboratory Cancer Research Trust, Genomics England Ltd., Oxford Science Enterprises PLC, and Trustee at the Rhodes Trust, The Ewelme Almshouse Charity, Biospring Management Partners LP, and Our Future Health UK.
Dr. Bell's former jobs include Chairman at Sensyne Health Ltd., Director at Genentech, Inc., Non-Executive Director at Roche Holding AG (from 2011 to 2020), Non-Executive Director at F.
Hoffmann-La Roche Ltd., Director at Atopix Therapeutics Ltd., and President of the Academy of Medical Sciences (from 2006 to 2011).
Dr. Bell's education includes a doctorate degree from Magdalen College School Oxford Ltd (conferred in 1990), an undergraduate degree from Magdalen College School Oxford Ltd (conferred in 1979), and an undergraduate degree from the University of Alberta (conferred in 1975).

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-05-22 13,452 ( 0.03% ) 455 888 $ 2024-06-29

John Bell active positions

CompaniesPositionStart
IMMUNOCORE HOLDINGS PLC Chairman -
Rhodes Trust Director/Board Member -
Director/Board Member -
Consultant / Advisor -
Office for Strategic Co-ordination of Health Research Chairman -
Director/Board Member -
The Ewelme Almshouse Charity Director/Board Member -
GMEC Management Co. Ltd. Chairman -
University of Oxford Corporate Officer/Principal 2001-12-31
░░░ ░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░ -
All active positions of John Bell

Former positions of John Bell

CompaniesPositionEnd
░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░ ░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░
See the detail of John Bell's experience

Training of John Bell

Magdalen College School Oxford Ltd Doctorate Degree
University of Alberta Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John Bell's experience

Connections

100 +

1st degree connections

27

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
ROCHE HOLDING AG

Health Technology

SENSYNE HEALTH PLC

Commercial Services

IMMUNOCORE HOLDINGS PLC

Health Technology

Private companies21

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Rhodes Trust

Commercial Services

Commercial Services

The Wellcome Trust Centre for Human Genetics

Oxford Centre for Diabetes Endocrinology & Metabolism

Oxford University Hospitals NHS Trust

Miscellaneous

The Gray Laboratory Cancer Research Trust

Commercial Services

GMEC Management Co. Ltd.

The Ewelme Almshouse Charity

Health Technology

Commercial Services

Office for Strategic Co-ordination of Health Research

Finance

Finance

Commercial Services

See company connections